Physician profile
Jeff Korab
NPI 1164749669
$1,627.04
in general payments reported to CMS, 2019-2025
13 companies · $97.66 in 2025
The $97.66 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,108 · 2024: $422 · 2025: $97.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $892 · Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $892.45 |
| Food and Beverage | $734.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,089.33 | 2023-2024 | |
| Mimedx Group, INC. | $101.75 | 2024 | |
| Abbvie INC. | $99.90 | 2023 | |
| Ibsa Pharma INC. | $46.19 | 2023-2025 | Tirosint, Tirosint, Flector |
| Nevro Corp. | $46.15 | 2024 | Senza |
| Bioventus LLC | $41.04 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Angiodynamics, INC. | $33.18 | 2025 | Auryon Laser System 100-120 Vac |
| Djo, LLC | $32.31 | 2024 | Cmf |
| Zimmer Biomet Holdings, INC. | $31.24 | 2023 | Juggerknotless Soft Anchor |
| Stryker Corporation | $31.03 | 2023 | Augment Injectable, Anchorage, Easyfuse |
| Horizon Therapeutics Plc | $30.17 | 2023 | Krystexxa |
| Amgen INC. | $28.95 | 2024-2025 | Krystexxa |
| Abbott Laboratories | $15.80 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Korab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.